SAN JOSE, Calif. (Reuters) -A U.S. prosecutor told jurors on Thursday that if Theranos founder Elizabeth Holmes had been truthful with investors and patients about her blood-testing startup, the venture never would have attracted critical funding and revenue.
"She chose fraud over business failure. She chose to be dishonest," Assistant U.S. Attorney Jeff Schenk told jurors at the start of closing arguments. "That choice was not only callous, it was criminal."
Already a subscriber? Log in.
Subscribe or renew your subscriptions to win prizes worth up to RM68,000!
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!